The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex

Neuropharmacology

Volumn 35, Issue 2, 1996, Pages 205-211

  Giacobini, E ^a   Zhu, X D ^a   Williams, E ^a   Sherman, K A ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

5 hydroxytryptamine; Acetylcholine; Acetylcholinesterase; Dopamine; E2020; Microdialysis; Norepinephrine

Indexed keywords

ACETYLCHOLINE; BIOGENIC AMINE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE; DYFLOS; NORADRENALIN; PIPERIDINE DERIVATIVE; SEROTONIN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG MECHANISM; DRUG SELECTIVITY; HYDROLYSIS; MALE; MICRODIALYSIS; MONOAMINE RELEASE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029937950     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(95)00157-3     Document Type: Article

References (27)

1. Baldwin H. A., De Souza R. J., Sarna G. S., Murray T. K., Green A. R. and Cross A. J. (1991) Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses. Br. J. Pharmac. 103: 1946-1950.
2. Beninger R. J. (1983) The role of dopamine in locomotor activity and learning. Brain Res. Rev. 6: 173-178.
3. Cuadra G., Summers K. and Giacobini E. (1994) Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmac. Exp. Ther. 270: 277-284.
4. Day J. and Fibiger H. C. (1992) Dopaminergic regulation of cortical acetylcholine release. Synapse 12: 281-286.
5. Decker M. W. and McGaugh J. L. (1991) The role of interactions between cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7: 151-156.
6. DeSarno P., Pomponi M., Giacobini E., Tang X. C. and Williams E. (1989) The effect of heptylphysostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat. Neurochem. Res. 14: 971-977.
7. El-Etri M. M., Ennis M., Jiang M. and Shipley M. T. (1993) Pilocarpine-induced convulsions in rats: Evidence for muscarinic receptor-mediated activation of locus coeruleus and norepinephrine release in cholinolytic seizure development. Exp. Neur. 121: 24-39.
8. Galli A., Mori F., Benini L. and Cacciarelli N. (1994) Acetylcholinesterase protection and the anti-diisopropyl-fluorophosphate efficacy of E2020. Eur. J. Pharmac. 270: 189-193.
9. Giacobini E. and Cuadra G. (1994) Second and third generation cholinesterase inhibitors: from preclinical studies to clinical efficacy. In: Cholinergic Basis for Alzheimer Therapy (Becker R. and Giacobini E., Eds), pp. 155-171. Birkhauser Boston, Cambridge.
10. Hallak M. and Giacobini E. (1986) Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat. Neurochem. Res. 11: 1037-1048.
11. Haroutunian V., Kanof P. D., Tsuboyama G. K. and Davis K. L. (1990) Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats. Brain Res. 507: 261-266.
12. Johnson C. D. and Russell R. L. (1975) A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Analyt. Biochem. 64: 229-238.
13. Memo M., Missale C., Trivelli L. and Spano P. F. (1988) Acute scopolamine treatment decrease dopamine metabolism in rat hippocampus and frontal cortex. Eur. J. Pharmac. 149: 367-374.
14. Messamore E., Ogane N. and Giacobini E. (1993a) Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum. Neuropharmacology 32: 291-296.
15. Messamore E., Warpman U., Ogane N. and Giacobini E. (1993b) Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology 32: 745-750.
16. Moroni F., Tanganelli S., Antonelli T., Carla V., Bianchi C. and Beani L. (1983) Modulation of cortical acetylcholine and gamma-aminobutyric acid release in freely moving guinea pigs: effects of clonidine and other adrenergic drugs. J. Pharmac. Exp. Ther. 236: 230-237.
17. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
18. Rogers S. L., Yamanishi Y. and Yamatsu K. (1991) E2020: the pharmacology of a piperidine cholinesterase inhibitor. In: Cholinergic Basis for Alzheimer Therapy (Becker R. and Giacobini E., Eds), pp. 314-320. Birkhauser Boston, Cambridge.
19. Santucci A. C., Haroutunian V. and Davis K. L. (1991) Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats. Clin. Neuropharmac. 14: 1-7.
20. Sherman K. A. (1991) Pharmacodynamics of oral E2020 and tacrine in humans: novel approaches. In: Cholinergic Basis for Alzheimer Therapy (Becker R. and Giacobini E., Eds), pp. 321-328. Birkhauser Boston, Cambridge.
21. Sherman K. A. and Messamore E. (1988) Blood cholinesterase as a guide to the efficacy of putative therapies for Alzheimer dementia: comparison of tacrine and physostigmine. In: Current Research in Alzheimer Therapy (Giacobini E. and Becker R., Eds), pp. 73-86. Taylor and Francis, New York.
22. Sherman K. A. and Messamore E. (1989) Cholinesterase inhibitor therapy for Alzheimer dementia: what do animal models tell us? Prog. Clin. Bioi Res. 317: 1209-1222.
23. Shih T.-M., Capacio B. R. and Cook L. A. (1993) Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman. Pharmac. Biochem. Behav. 44: 615-622.
24. Vizi E. S. (1980) Modulation of cortical release of acetylcholine and norepinephrine released from nerves arising from the rat locus coeruleus. Neuroscience 5: 2139-2144.
25. Wise R. A. (1978) Catecholamine theories of reward: a critical review. Brain Res. 152: 215-219.
26. Xu M., Mizobe F., Yamamoto T. and Kato T. (1989) Differential effects of M1 and M2-muscarinic drugs on striatal dopamine release and metabolism in freely, moving rats. Brain Res. 495: 232-242.
27. Yamanishi Y., Araki A., Kosasa T., Ogura H. and Yamatsu K. (1988) Neurochemical studies of E2020, a novel centrally acting acetylcholinesterase inhibitor. Soc. Neurosci. Abst. 14: 99.